BrainChip Opens Sequora Edge AI IP for Licensing With Generative AI Support

BrainChip's Sequora edge AI processor IP is now open for commercial licensing, bringing on-device generative AI of up to ~3 billion parameters to automotive, medical, defence and industrial customers right on its May 2026 roadmap timeline.
By Josua Ferreira -
  • BrainChip's Sequora processor IP has completed development and is available for commercial licensing as of 14 October 2026, delivered to the timeline set in its May 2026 roadmap.
  • Sequora brings generative AI and LLM capabilities on-device, supporting models up to about 3 billion parameters while keeping Akida's ultra-low power, no-cloud operation.
  • Enhanced run-time branching targets automotive, medical and avionics certification, opening the door to regulated, high-value markets.
  • BrainChip has disclosed no licensee names, pricing or revenue expectations and says it cannot reliably forecast licensing revenue or adoption.
  • The next proof points are first licensing agreements, customer adoption announcements and further roadmap milestones, with customer engagement already underway.
Summarise with AI:

Sequora edge AI processor IP now available for commercial licensing

BrainChip (ASX: BRN) advised on 14 October 2026 that its Sequora™ processor intellectual property (IP) core has completed development and is now available for commercial licensing to semiconductor and system developers.

Sequora is designed to enable generative AI workloads for edge-based applications where power efficiency, memory utilisation and local processing capabilities are important design considerations.

The company stated the release is being delivered to the timeline outlined in its May 2026 roadmap presentation. That positions the announcement as delivery against a stated plan.

Sean Hehir, CEO

“Sequora is an important next step in our technology roadmap, and is being delivered to the timeline outlined in our May 2026 roadmap presentation…”

Mr Hehir said the availability of Sequora expands BrainChip’s product portfolio and addresses applications requiring generative AI capabilities within edge devices. For investors, delivery to a previously outlined timeline is a data point on roadmap execution.

What Sequora delivers on a single piece of silicon

According to the announcement, Sequora provides edge AI advantages on the one piece of silicon. It maintains existing Akida™ advantages and adds new capabilities.

Capability Detail
Ultra-low power operation Continues to run on ultra-low power, maximising battery life (existing Akida advantage)
No reliance on cloud connection Maintains data sovereignty and high speed computation, while minimising cloud costs (existing Akida advantage)
Generative AI and LLM capabilities Brings Generative AI and LLM capabilities to the device (new)
Supported model sizes Up to **~3 billion parameters** (new)
Battery-limited model capabilities Expands model capabilities that are currently limited by battery size (new)
Run-time branching Enhanced to enable automotive, medical and avionics certification (new)

The announcement does not provide performance benchmarks beyond those listed. The additions suggest a broader set of use cases than the existing Akida capabilities alone, though the source does not quantify this.

How generative AI at the edge works, and why it matters

Edge AI refers to processing data on the device itself rather than sending it to the cloud. A large language model (LLM) is an AI system built to work with human language, and these models are generally demanding to run on small, battery-powered devices.

Sequora is being offered as semiconductor IP licensed to customers to incorporate into their own system-on-chip designs. The commercial offering includes a comprehensive suite of related software and development tools.

Sequora Target Application Sectors

Semiconductor IP licensing means BrainChip supplies the design rather than a finished chip. The announcement does not disclose any pricing, royalty or fee structures.

BrainChip’s existing ASICLAND IP licence agreement shows how this model works in practice, with upfront licence fees, volume-based royalties on net sales and BrainChip retaining full ownership of the underlying IP.

Potential application areas named by the company are:

  • Industrial
  • Automotive
  • Aerospace and defence
  • Consumer
  • Medical

Investors exploring the sectors named above can read our full explainer on BrainChip’s edge AI strategy across defence, wearables and space, which covers the September 2026 investor webinar, the patent portfolio and live Akida deployments.

What investors should watch next

The announcement describes the notice as “a key milestone in the commercialisation of Sequora”. BrainChip has commenced customer engagement activities.

The company stated it is not currently in a position to provide reliable forecasts regarding future licensing revenue, customer adoption rates or financial impact. Any future material customer contracts or developments will be disclosed in accordance with its continuous disclosure obligations.

Items investors may wish to monitor include:

  1. First licensing agreements
  2. Customer adoption announcements
  3. Further roadmap milestones

The announcement does not disclose licensee names, pricing or revenue expectations, so these remain open questions.

Get Tech News Before the Market Moves

Join 20,000+ investors receiving FREE breaking ASX news within minutes of release, complete with in-depth analysis and the full announcement. Click the “Free Alerts” button at Big News Blast to get the next tech catalyst in your inbox the moment it breaks.


Frequently Asked Questions

What is the BrainChip Sequora edge AI processor?

Sequora is a processor intellectual property core from BrainChip that brings generative AI and large language model capabilities to edge devices. It keeps Akida's ultra-low power and no-cloud advantages and supports models up to about 3 billion parameters.

What is semiconductor IP licensing?

Semiconductor IP licensing means a company supplies a chip design rather than a finished chip, and customers build it into their own system-on-chip designs. BrainChip's ASICLAND agreement, for example, uses upfront licence fees and volume-based royalties.

When did BrainChip make Sequora available for licensing?

BrainChip announced on 14 October 2026 that Sequora had completed development and was available for commercial licensing. The company said delivery matched the timeline in its May 2026 roadmap presentation.

What industries is Sequora aimed at?

BrainChip names industrial, automotive, aerospace and defence, consumer and medical as potential application areas. Enhanced run-time branching is designed to support automotive, medical and avionics certification.

What should investors watch after the Sequora announcement?

Key items are first licensing agreements, customer adoption announcements and further roadmap milestones. BrainChip has not disclosed licensee names, pricing or revenue expectations, and says it cannot yet forecast licensing revenue.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher